Načítá se...
INT-004 Physicochaemical stability of carfilzomib (kyprolis(®)) containing solutions after reconstitution and ready-to-administer preparations
BACKGROUND: Carfilzomib (Kyprolis(®)) is a second-generation, selective and irreversible proteasome inhibitor. Profound knowledge about the physicochemical stability is necessary in order to determine the ‘beyond-use-dates’ of the reconstituted and diluted ready-to-administer preparations. PURPOSE:...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535261/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.529 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|